SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-177138
Filing Date
2015-05-07
Accepted
2015-05-07 16:17:30
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d899508d10q.htm 10-Q 393960
2 EX-10.1 d899508dex101.htm EX-10.1 33401
3 EX-10.2 d899508dex102.htm EX-10.2 7996
4 EX-31.1 d899508dex311.htm EX-31.1 6782
5 EX-32.1 d899508dex321.htm EX-32.1 4413
  Complete submission text file 0001193125-15-177138.txt   2298283

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acad-20150331.xml EX-101.INS 245814
7 XBRL TAXONOMY EXTENSION SCHEMA acad-20150331.xsd EX-101.SCH 22056
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20150331_cal.xml EX-101.CAL 41015
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20150331_def.xml EX-101.DEF 52027
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20150331_lab.xml EX-101.LAB 171885
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20150331_pre.xml EX-101.PRE 116790
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 15841991
SIC: 2834 Pharmaceutical Preparations